Nalini Singh
Nalini Singh
M.D., M.P.H.
Professor
Secondary Appointment
School: Milken Institute School of Public Health
Department: Global Health
Contact:
Email:
Nalini Singh
Milken Institute School of Public Health
950 New Hampshire Avenue, NW, Floor 4
Washington DC 20052
Nalini Singh, MD, MPH is Professor Emeritus-in-residence of Pediatrics, School of Medicine and Health Care Sciences and Professor, and Global Health in the School of Public Health, The George Washington University, Washington, D.C. Dr. Singh has worked for over three decades in infectious diseases and infection prevention, including as Chair of the Division of Pediatric Infectious Diseases at Children’s National for twelve years (2000-2012). She is recipient of several awards and honors, including the Pediatric Scholarship award in 2016 from the Society of Healthcare Epidemiology of America. She is a Fellow of Infectious Disease Society of America (IDSA), Society of Healthcare Epidemiology of America (SHEA), and Pediatric Infectious Diseases Society; a past member of Practice and Guidelines committee of IDSA, was the Chair of External Affairs Committee of SHEA during 2013-2014, and a member of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC).
Dr. Nalini Singh received her Pediatric training at the University of Massachusetts Medical Center and her Infectious Diseases training at the National Institute of Health. She has a Master of Public Health and Graduate certificate in Health Information Technology from the George Washington University. In 2009, Dr. Singh was Fulbright Scholar and worked at Amrita Institute of Medical Sciences in India to establish antimicrobial stewardship program for containment of antibiotic resistant bacteria.
- MPH, 1994, George Washington University
- Fellowship Program, Pediatric Infectious Diseases, 1982, National Institutes of Health
- Residency Program, Pediatrics, 1979, University of Massachusetts Medical Ctr
- Internship Program, Flexible Internship, 1976, Boston University Hospital
- BS, Pre-Med, 1969, Benares Hindu University
- MBBS, 1969, Benares Hindu University
- Changing Epidemiology of Clostridium DifficileAssociated Disease in Children, (2007) Infection Control Hospital Epidemiology
- Control of Vancomycin Resistant Enterococci in the Neonatal Intensive Care Unit, (2005) Infection Control Hospital Epidemiology
- Epidemiology of Clostridium Difficile in Infants Younger than Two Years of Age, (2008) Society of Healthcare Epidemiology
- Epidemiology of Infection and Colonization with VancomycinResistant Enterococci and Frequency of Cocolonization with MethicillinResistant Staphylococcus Aureus in Children, (2007) Infection Control Hospital Epidemiology
- Epidemiology of Invasive Group A Streptococcus Infections in Children Society of Pediatric Research, (2008) Pediatric Academic Societies
- Molecular and Descriptive Epidemiology of Multidrugresistant Enterobacteriaceae in Hospitalized Infants, (2008) Infection Control Hospital Epidemiology
- Society of Healthcare Epidemiology, (2008) Clinical and economic impact of Methicillin-resistant Staphylococcus aureus on patients in the neonatal intensive care unit
- Society of Pediatric Research, (2008) The Increasing Incidence of Community-Associated Methicillin Resistant Staphylococcus aureus (MRSA) in Hospitalized Neonates
- St Judes Pediatric Society Meeting, (2008) The Evolution of Methicillin-resistant Staphylococcus aureus in Neonates
Dr. Singh is nationally selected as Research Mentor for medical students awarded internships by the Society of Pediatric Research. She was a preceptor for and advisor of George Washington University’s Doctoral candidates in Public Health Program and mentors’ graduate students, medical students, fellows, junior faculty members and Society of Health Care Epidemiology of America (SHEA)International Ambassadors.
Dr. Singh area of research is infectious diseases, Infection Prevention and control/Antimicrobial Resistance and maternal child health. She was a member of WHO’s Guidelines committee and expert steering group supporting Infection Prevention Control unit. She is a consultant to the United Nations’ (PAHO/WHO) Infection prevention program and was consultant to the CDC from 2016-2019 where she worked on the development of guidelines for prevention of transmission of MRSA and central line-associated infections in neonatal intensive care unit. In the era of COVID-19 Pandemic she was involved in infection prevention initiatives and use of novel technologies - cold adaptive plasma for inactivating SARS-COV-2 virus with colleagues from GWU.
She is involved in spreading the message of infection prevention.